Amiodarone 150 Mg Injection Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Injection

Available Strengths: 150 mg/3 mL and 500 mg/10 mL

Reference Brands: Cordarone, Pacerone(US)

Category: Critical Care

Amiodarone is a key antiarrhythmic drug available in 100–400 mg tablets and 50 mg/mL IV vials. Used for serious ventricular arrhythmias, brands include Cordarone and Amiodarone Hameln. Commonly supplied to hospitals and ICUs, it is a staple in pharma B2B cardiac care procurement and institutional sourcing platforms. Amiodarone 150 mg Injection is available in Intravenous (IV) Injection and strengths such as 150 mg/3 mL and 500 mg/10 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Amiodarone 150 mg Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Amiodarone 150 mg Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Amiodarone is a broad-spectrum antiarrhythmic medication used for the treatment and prevention of life-threatening ventricular arrhythmias and atrial fibrillation. It is available in both oral (100 mg, 200 mg, 400 mg tablets) and IV (50 mg/mL) forms, typically supplied in 3 mL and 10 mL vials. Amiodarone works by prolonging the cardiac action potential and refractory period. Brands like Cordarone and Pacerone are widely used in the US, while the EU features Cordarone, Amiodarone Hameln, and Accord. Amiodarone is a high-priority cardiac care drug sourced through pharma B2B supply chains by hospitals, clinics, and institutional buyers.